Skip to content
Trial Eligibility
Menu

Restructuring the Alpha-Gamma Code in Aging Vision

NCT07208318

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Tests whether age-related visual deficits arise from disrupted alpha-gamma coupling in visual cortex (V1) and MT. Uses fMRI, source-resolved HD-EEG, and personalized complex-waveform HD-tACS to (1) quantify aging effects on phase-amplitude coupling, (2) drive PAC into a preferred "gamma-at-alpha-troughs" state, and (3) bidirectionally change perception by aligning gamma to alpha troughs vs peaks.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Aging
  • Visual Perception
  • Noninvasive Brain Stimulation

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Boston University Charles River Campus
Last updated on ClinicalTrials.gov
July 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • 111 Cummington Mall, Boston University · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.